Another Indian firm under fire for shoddy clinical trials work LONDON/ MUMBAI, July 7- Another Indian clinical research organisation, Quest Life Sciences of Chennai, is in trouble over defective trials work, according to a warning issued by the World Health Organization. The action by the United Nations health agency follows an earlier scandal over drug testing at GVK Biosciences, which resulted in approvals for hundreds...
| By: Ben Hirschler and Zeba Siddiqui
China markets tumble despite beefed-up support measures; HK down 1.2 pct SHANGHAI, July 7- Chinese stocks plummeted yet again on Tuesday morning, defying rapid-fire emergency support measures from Beijing and raising concerns about policy makers' ability to stabilise one of the most highly volatile markets in the world. The CSI300 index tracking China's biggest companies opened down 3 percent and ended the morning 4.4 percent...
RBA holds rates at 2%, says Aussie still too strong Australia's central bank held interest rates at record lows on Tuesday as sliding commodity prices, a still-high currency and mounting economic uncertainty in China argue for continued stimulus, and even the chance of more cuts.
5 trades on oil's steep decline "Fast Money" traders discussed which stocks to buy as U.S. crude oil fell to its lowest level since April.
| By: Jacob Pramuk
With rates at record low, where does the RBA go next? The Reserve Bank of Australia (RBA) is set to meet on Tuesday against a backdrop of improving economic conditions at home but increased uncertainty abroad as Greece drama continues to unfold and concerns of a credit bubble in China linger.
| By: Ansuya Harjani